Arti Hurria, MD, of the City of Hope, discusses ways to incorporate the principles of geriatrics into oncology care and offer targeted interventions for older survivors.
Flora E. van Leeuwen, PhD, of the Netherlands Cancer Institute, discusses cardiovascular disease risk after treatment-induced primary ovarian insufficiency in female survivors of Hodgkin lymphoma (Abstract 114).
Lynda M. Beaupin, MD, of the Roswell Park Cancer Institute, discusses her findings on the factors contributing to adolescent and young adult cancer survivors not seeking follow-up care (Abstract 29).
Christopher J. Recklitis, PhD, MPH, of Dana-Farber Cancer Institute, discusses a study investigating the availability of supportive care sexual aids and resources for cancer survivors at U.S. cancer centers (Abstract 134).
David Baraghoshi, of the Huntsman Cancer Institute at the University of Utah, discusses an assessment of cardiovascular risk more than 10 years after diagnosis for colorectal cancer survivors compared with a cancer-free general population cohort (Abstract 113).
Lawrence N. Shulman, MD, of Abramson Cancer Center at the University of Pennsylvania, discusses the Commission on Cancer’s efforts to promote robust survivorship care and how its new recommendations will affect clinical practice and patients.
